CRAIG PENDERGRASS: Open Payments
NPI 1700835469 · NEOSHO, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 49 payments from 13 companies in 2025. Trend: 2023 $1,497 · 2024 $1,715 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $173 |
| AstraZeneca Pharmaceuticals LP | 7 | $163 |
| Novo Nordisk Inc | 9 | $139 |
| PFIZER INC. | 4 | $78 |
| Aimmune Therapeutics, Inc. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $16 |
Products named: Ozempic, OTEZLA, FARXIGA, NURTEC ODT, BREZTRI, EVENITY, ZENPEP, Veozah.
Industry payments across MO — which companies pay providers there.
